Nomad Power Solutions NMAD
NASDAQ NMAD
$3.71 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nomad Power Solutions (NMAD) Current Assets (2010 - 2026)

Nomad Power Solutions (NMAD) posted Current Assets of $19.3 million for Q2 2026, up 272.68% on a QoQ basis from $5.2 million in Q4 2025, and up 1849.88% year-over-year from $989752.0 in Q2 2025.

Analysis

Nomad Power Solutions (NMAD) Current Assets (2010 - 2026) Analysis & Trends

Nomad Power Solutions has reported Current Assets for 17 years, with the latest figure at $19.3 million in Q2 2026.

  • On a quarterly basis, Current Assets rose 1849.88% year-over-year to $19.3 million in Q2 2026; TTM through Jun 2026 was $19.3 million, a 1849.88% increase from a year earlier, with the FY2025 full-year figure at $5.2 million, up 352.06% from the prior year.
  • Current Assets was $19.3 million for Q2 2026 at Nomad Power Solutions, up from $5.2 million in the prior quarter.
  • The five-year high for Current Assets was $19.3 million in Q2 2026, with the low at $989752.0 in Q2 2025.
  • Average Current Assets over 5 years is $5.1 million, with a median of $4.3 million recorded in 2023.
  • The sharpest annual moves came in 2024 and 2026: Current Assets sank 73.41% in 2024, then jumped 1849.88% in 2026.
  • Over 5 years, Current Assets stood at $5.6 million in 2022, then dropped by 22.52% to $4.3 million in 2023, then tumbled by 73.41% to $1.1 million in 2024, then jumped by 352.06% to $5.2 million in 2025, then surged by 272.68% to $19.3 million in 2026.
  • The last three Current Assets figures came in at $19.3 million (Q2 2026), $5.2 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 34.96 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 13.95 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 12.54 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 18.45 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 8.07 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.82 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 4.62 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 7.31 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 4.74 Bn
10 Nomad Power Solutions 49.59 Mn 49.59 Mn - 19.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.30 Mn
Dec 31, 2025 5.18 Mn
Sep 30, 2025 5.43 Mn
Jun 30, 2025 989,752.00
Dec 31, 2024 1.15 Mn
Sep 30, 2024 1.69 Mn
Jun 30, 2024 2.67 Mn
Mar 31, 2024 3.59 Mn
Dec 31, 2023 4.31 Mn
Sep 30, 2023 5.23 Mn
Jun 30, 2023 3.10 Mn
Mar 31, 2023 4.33 Mn
Dec 31, 2022 5.56 Mn
Sep 30, 2022 6.82 Mn
Jun 30, 2022 8.02 Mn
Mar 31, 2022 4.11 Mn
Dec 31, 2021 5.09 Mn
Sep 30, 2021 6.31 Mn
Jun 30, 2021 7.24 Mn
Mar 31, 2021 7.89 Mn